CD33 and Huntington disease: In addition, we also observed increased expression of TNF in blood CD4+ cells (Cluster 17) of patients with MCI, AD and HD, as well as increased CD130, TREM2 and CD33 expression in CSF double-negative (DN) T cells (Cluster 14) of AD and MCI patients (Fig. 1i).